Selection and fading of resistance mutations in women and infants receiving nevirapine to prevent HIV-1 vertical transmission (HIVNET 012).

SH, Eshleman; M, Mracna; LA, Guay; M, Deseyve; S, Cunningham; M, Mirochnick; P, Musoke; T, Fleming; Fowler M, Glenn; LM, Mofenson; F, Mmiro; JB, Jackson

doi:10.1097/00002030-200110190-00006

Public

Selection and fading of resistance mutations in women and infants receiving nevirapine to prevent HIV-1 vertical transmission (HIVNET 012).

Shared by NobleBlocks on Oct 1, 2001 • 12:00 AM UTC

Authors:

Eshleman SH

Mracna M

Guay LA

Abstract

<h4>Objective</h4>To examine the emergence and fading of NVP resistance (NVP(R)) mutations in HIV-1-infected Ugandan women and infants who received single dose NVP to prevent HIV-1 vertical transmission.<h4>Design</h4>We examined NVP(R) in women and infants who received NVP in the HIVNET 012 clinica...

Discussions